miR-1 Is a Novel Biomarker for Polymyositis/dermatomyositis-associated Interstitial Lung Disease
2019
AbstractObjectives: Although intensive
immunosuppressivetreatment is necessary for the severe cases with
polymyositis(PM)/
dermatomyositis(DM), the prognostic factors or disease activity indices ...
Keywords:
-
Correction
-
Source
-
Cite
-
Save
25
References
3
Citations
NaN
KQI